The effect of Reflexology in patients with Fibromyalgia

IF 1 4区医学 Q3 EMERGENCY MEDICINE

Signa Vitae Pub Date : 2021-09-15 DOI:10.22514/sv.2021.175

S. Raptopoulou, M. Kouri, A. Vadalouka, A. Tsaroucha

{"title":"The effect of Reflexology in patients with Fibromyalgia","authors":"S. Raptopoulou, M. Kouri, A. Vadalouka, A. Tsaroucha","doi":"10.22514/sv.2021.175","DOIUrl":null,"url":null,"abstract":"Aim: This study is to investigate the effect of Reflexology as an add-on treatment in patients with Fibromyalgia, receiving pregabalin as treatment. Method: The study was conducted from September 2017 to February 2020. 79 patients (74 women and 5 men) with a mean age of 54.6 years were included. Inclusion criteria: - Diagnosis of Fibromyalgia >1 year\n- Duration of pain >1 year\n- Pain intensity >6 on VAS scale\n- Not using Reflexology in the pastResults:\n- Primary endpoint: Reduction of pain scores more than 30% in 3 months.\n- Secondary endpoints: Functionality (in terms of rigidity and workability) in 3 months.In all patients, the diagnosis of Fibromyalgia was made by completing the FIRST (Fibromyalgia Rapid Screening Tool) questionnaire (Greek version). The evaluation of the results was done with the pain intensity questionnaire in scale VAS as well as with observation, interviews, diaries.All patients received Pregabalin medication at a recommended dose of 75–600 mg daily.44 patients (56%) received normal medication. A mean reduction in pain of >50% was recorded.35 patients (44%) did not reach the maximum dose due to side effects and the drug was stopped at 450 mg daily. These patients received 14, 20-min Reflexology sessions, in 12 weeks, in order to achieve the desired analgesic effect.There was a reduction of pain >65% and a significant improvement in the secondary endpoints of functionality (significantly reduced morning stiffness, increased ability to work).Conclusions: Reflexology may be beneficial as add-on treatment in patients with Fibromyalgia who are unable to receive the recommended dosages of their medication.","PeriodicalId":49522,"journal":{"name":"Signa Vitae","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Signa Vitae","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.22514/sv.2021.175","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Aim: This study is to investigate the effect of Reflexology as an add-on treatment in patients with Fibromyalgia, receiving pregabalin as treatment. Method: The study was conducted from September 2017 to February 2020. 79 patients (74 women and 5 men) with a mean age of 54.6 years were included. Inclusion criteria: - Diagnosis of Fibromyalgia >1 year - Duration of pain >1 year - Pain intensity >6 on VAS scale - Not using Reflexology in the pastResults: - Primary endpoint: Reduction of pain scores more than 30% in 3 months. - Secondary endpoints: Functionality (in terms of rigidity and workability) in 3 months.In all patients, the diagnosis of Fibromyalgia was made by completing the FIRST (Fibromyalgia Rapid Screening Tool) questionnaire (Greek version). The evaluation of the results was done with the pain intensity questionnaire in scale VAS as well as with observation, interviews, diaries.All patients received Pregabalin medication at a recommended dose of 75–600 mg daily.44 patients (56%) received normal medication. A mean reduction in pain of >50% was recorded.35 patients (44%) did not reach the maximum dose due to side effects and the drug was stopped at 450 mg daily. These patients received 14, 20-min Reflexology sessions, in 12 weeks, in order to achieve the desired analgesic effect.There was a reduction of pain >65% and a significant improvement in the secondary endpoints of functionality (significantly reduced morning stiffness, increased ability to work).Conclusions: Reflexology may be beneficial as add-on treatment in patients with Fibromyalgia who are unable to receive the recommended dosages of their medication.

查看原文本刊更多论文

反射疗法在纤维肌痛患者中的作用

目的:探讨反射疗法对普瑞巴林治疗的纤维肌痛患者的辅助治疗效果。方法:研究时间为2017年9月至2020年2月。79例患者(女性74例，男性5例)，平均年龄54.6岁。纳入标准:-纤维肌痛诊断>1年-疼痛持续时间>1年-疼痛强度>6 (VAS评分)-过去未使用反射疗法结果:-主要终点:3个月内疼痛评分降低30%以上。次要终点:3个月内的功能性(根据刚性和可加工性)。在所有患者中，通过完成FIRST(纤维肌痛快速筛查工具)问卷(希腊版本)来诊断纤维肌痛。采用VAS量表疼痛强度问卷及观察、访谈、日记等方法对结果进行评价。所有患者均以每日75-600毫克的推荐剂量服用普瑞巴林。44例(56%)患者接受正常药物治疗。疼痛平均减轻50%。35名患者(44%)由于副作用未达到最大剂量，药物停药至每日450毫克。这些患者在12周内接受14次，20分钟的反射疗法，以达到预期的镇痛效果。疼痛减轻了65%，次要功能指标也有显著改善(晨僵明显减少，工作能力增强)。结论:反射疗法可能是有益的附加治疗纤维肌痛患者谁不能接受推荐剂量的药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Signa Vitae 医学-急救医学

CiteScore

1.30

自引率

9.10%

发文量

审稿时长

3 months

期刊介绍： Signa Vitae is a completely open-access，peer-reviewed journal dedicate to deliver the leading edge research in anaesthesia, intensive care and emergency medicine to publics. The journal’s intention is to be practice-oriented, so we focus on the clinical practice and fundamental understanding of adult, pediatric and neonatal intensive care, as well as anesthesia and emergency medicine. Although Signa Vitae is primarily a clinical journal, we welcome submissions of basic science papers if the authors can demonstrate their clinical relevance. The Signa Vitae journal encourages scientists and academicians all around the world to share their original writings in the form of original research, review, mini-review, systematic review, short communication, case report, letter to the editor, commentary, rapid report, news and views, as well as meeting report. Full texts of all published articles, can be downloaded for free from our web site.